Tuesday, November 17, 2020

BioAtla Files For IPO

San Diego-based biotech BioAtla has filed for an IPO, saying that it is looking to raise up to $100M in an IPO on the Nasdaq Global Market as BCAB. The IPO is being underwritten by J.P. Morgan, Jefferies, Credit Suisse, and BTIG. BioAtla is venture backed by Himalaya Parent LLC, Pfizer Ventures, Soleus Private Equity, HBM Healthcare Investments, Baker Bros. Advisors, Cormorant Asset Management, and Zone II Healthcare Holdings. BioAtla is a clinical-stage biopharmaceutical company developing a class of highly specific and selective antibody-based therapeutics for the treatment of solid tumor cancer.